We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Bogdan Cristian Dinu
Mar 17, 2021
curative intent. seem to be more accurate.
Comment deleted by Moderator.
Feng-Jen Chen
Mar 19, 2021
Endocrine therapy with ovarian suppression/AI/CDK4/6 inhibitor
Rafaat Bakheet
Mar 19, 2021
endocrine therapy with ovarian suppression / AI/ CDK4/6 inhibitor
Mahmoud Soliman
Mar 19, 2021
Curative intent
Kimberly Langdon
Mar 19, 2021
Endocrine therapy with Ovarian suppression/AI treatment Metastatic disease is generally not curable
Eduardo Medeiros
Mar 20, 2021
Treat with curative intent as described with SBRT in metastatic areas and long term ádjuvant"endocrine therapy with AI/CDK4/6 inhibitor. Despite incurable disease this approach will probably bring the best long term survival...
robert kwiatkowski
Mar 21, 2021
Curative intent with SBRT
Lee Schwartzberg
Apr 04, 2021
Would treat the oligometastatic disease with SBRT and then begin AI/CDK 4/6 inhibitor. If still in remission at 2 years, stop the CDK and continue AI with close followup.
Apr 18, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Ana
C.
Sandoval Leon
MD
Bogdan Cristian Dinu
Mar 17, 2021
Feng-Jen Chen
Mar 19, 2021
Rafaat Bakheet
Mar 19, 2021
Mahmoud Soliman
Mar 19, 2021
Kimberly Langdon
Mar 19, 2021
Eduardo Medeiros
Mar 20, 2021
robert kwiatkowski
Mar 21, 2021
Lee Schwartzberg
Apr 04, 2021
Apr 18, 2024
Pending Moderator approval.